BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Europabio - ECPv6.15.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.europabio.org
X-WR-CALDESC:Events for Europabio
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260506T080000
DTEND;TZID=Europe/Brussels:20260506T200000
DTSTAMP:20260525T184238
CREATED:20260219T124023Z
LAST-MODIFIED:20260219T124028Z
UID:9479-1778054400-1778097600@www.europabio.org
SUMMARY:BioPharmaChem Impact 2026
DESCRIPTION:BioPharmaChem 2026 will bring together leading business leaders and experts on many pertinent topics including: realising the potential of the ecosystem\, sustainability\, digitalisation\, the power of partnerships\, resilient supply chains\, the future of work\, EU competitiveness and more. \n\n\n\nDelegates will enjoy unmissable networking opportunities to connect with many biopharmaceuticals\, pharmaceuticals and chemicals professionals in our bespoke exhibition area. \n\n\n\nThe Awards Dinner will honour excellence in the BioPharmaChem sector and celebrate the remarkable contributions and innovations that are shaping the future of our industry. This will provide a fitting end to a truly engaging event. \n\n\n\n \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/biopharmachem-impact-2026/
CATEGORIES:External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-41.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260512T080000
DTEND;TZID=Europe/Brussels:20260513T200000
DTSTAMP:20260525T184238
CREATED:20260424T101919Z
LAST-MODIFIED:20260424T101921Z
UID:9605-1778572800-1778702400@www.europabio.org
SUMMARY:EFGCP Conference 2026
DESCRIPTION:EuropaBio is supporting EFGCP Conference 2026. \n\n\n\nEurope is at a defining moment for clinical research. The Clinical Trials Regulation set out a powerful vision: a continent united by transparency\, collaboration\, and efficient access to innovation. While its implementation brought both progress and pressure\, it confirmed something essential—Europe’s commitment to ethics\, quality\, and patient protection remains unwavering. \n\n\n\nNational ethical review is a vital strength of Europe’s clinical research landscape. Ethics committees play a key role in ensuring trials uphold human dignity\, scientific integrity\, and public trust. Their contribution\, together with the regulatory authorities’ risk-benefit review\, forms the foundation of a credible and high‑quality research ecosystem. By further strengthening the collaborative partnership\, Europe can achieve an ethical review process that is both protective and efficiently aligned with the needs of modern clinical research. \n\n\n\nToday\, national ethical review stands at the centre of the conference discussion. Ethics committees face growing complexity; sponsors navigate longer reviews and more information requests. These challenges highlight not failure\, but opportunity: the chance to rethink how Europe aligns ethical excellence with operational efficiency. \n\n\n\nIn addition\, the European Commission’s proposed new Biotech Act offers a fresh pathway—clearer roles\, streamlined processes\, and modern ethical standards grounded in the 2024 Declaration of Helsinki. It invites us to shape a system worthy of Europe’s innovation leadership ambitions. \n\n\n\nThe EFGCP Conference 2026 is where this work begins. Here\, stakeholders from across Europe come together to share best practice experiences\, challenge assumptions\, and co‑create practical solutions to optimise the system. Our goal is simple and ambitious: to strengthen participant protection while enabling efficient\, faster\, more predictable clinical trial authorisations and start up times. \n\n\n\nTogether\, we have the opportunity to build an ethical review model that reflects Europe at its best—responsible\, collaborative\, transparent and ready to lead the next chapter of global research. \n\n\n\n\nMore Info & Registration Here
URL:https://www.europabio.org/event/efgcp-conference-2026/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/04/Event-Banners-Website.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260519T080000
DTEND;TZID=Europe/Brussels:20260521T200000
DTSTAMP:20260525T184238
CREATED:20260312T090221Z
LAST-MODIFIED:20260312T090324Z
UID:9518-1779177600-1779393600@www.europabio.org
SUMMARY:EU Pharmaceutical Law Forum 2026
DESCRIPTION:We are thrilled to announce our partnership with the EU Pharmaceutical Law Forum\, one of the most significant events for legal and compliance professionals in the pharmaceutical industry.This forum is a cornerstone for discussing the latest developments in EU pharmaceutical law\, regulatory frameworks\, and compliance strategies. It brings together industry leaders\, legal experts\, and policymakers to address critical challenges and opportunities\, shaping the future of healthcare and pharmaceuticals in Europe.As part of our partnership\, we are delighted to offer 15% off registration* to our audience! Don’t miss this opportunity to gain valuable insights\, network with key stakeholders\, and stay ahead in the ever-evolving pharmaceutical landscape. \n\n\n\n*This discount is applicable to Life Sciences Manufacturers only. Other restrictions may apply. \n\n\n\nDiscount code: EUPLEUBIO26 \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/eu-pharmaceutical-law-forum-2026/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/03/Event-Banners-Website-3.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260603T080000
DTEND;TZID=Europe/Brussels:20260604T200000
DTSTAMP:20260525T184238
CREATED:20260113T081624Z
LAST-MODIFIED:20260113T081823Z
UID:9392-1780473600-1780603200@www.europabio.org
SUMMARY:ECRD 2026: Rare Diseases in a changing & Competitive Europe
DESCRIPTION:ECRD is the largest\, patient-led policy-shaping conference for rare diseases in Europe. The event is an instrumental tool for advancing policy objectives that improve the lives of people living with a rare disease. The overarching title of ECRD 2026 is: Rare Diseases in a Changing & Competitive Europe: Shaping policies to address the unmet needs of people living with rare diseases.  \n\n\n\nRare disease research has long driven breakthroughs in more common conditions\, reinforcing Europe’s role as a global leader in biotechnology and precision medicine. Investing in this field is not only a moral imperative—it is a strategic move to boost Europe’s competitiveness in the life sciences. This is especially crucial in the context of the deployment of the Life Science Strategy and of the adoption of the Biotech Act.  \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/ecrd-2026-rare-diseases-in-a-changing-competitive-europe/
CATEGORIES:External,Healthcare Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/01/Event-Banners-Website-32.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260610T080000
DTEND;TZID=Europe/Brussels:20260611T200000
DTSTAMP:20260525T184238
CREATED:20260216T122037Z
LAST-MODIFIED:20260422T072615Z
UID:9464-1781078400-1781208000@www.europabio.org
SUMMARY:Bio Innovations Europe 2026
DESCRIPTION:EuropaBio is joining Bio Innovations Europe 2026 as a Headline Partner. \n\n\n\nTaking place on 10-11 June 2026 in The Hague\, the event—formerly known as World Bio Markets—has seen exponential growth. Since its 2022 relaunch\, pre-arranged meetings have surged from 160 to over 1\,050 in 2025—a 550% increase. The 2026 edition is set to be the largest yet\, hosting more than 400 attendees and facilitating 1\,500 commercial meetings between bio-developers & producers\, chemical manufacturers\, consumer brands & intermediates\, community enablers\, investors & financiers and suppliers. \n\n\n\nDelivering the Biotech future of Europe: EuropaBio at Bio-Innovations \n\n\n\nEuropaBio\, the industry association that champions innovative bioindustries\, is proud to host a dedicated programme together with partner Bio-Innovations. \n\n\n\nEFIB presents Europe’s key opinion leaders\, bringing a clear statement to legislators at EU and national levels. 2026 brings legislation for simplification\, defragmentation and acceleration of biotechnology as a vital global technology and Europe must ensure that it can compete in the global race to dominance for biotechnology and biomanufacturing. \n\n\n\nIn addition to an opening keynote\, where the 2026 EFIB Statement will be launched\, EuropaBio\, through its EFIB platform\, will also host dedicated workshops: \n\n\n\nExecutive Round Table: Senior stakeholders from across the corporate\, policy and scientific community will discuss the priorities for Europe in 2026 and the ambition that must be delivered through legislative programmes that include the Bioeconomy Strategy\, Biotech Act and Food and Feed Safety Omnibus\, in addition to industrial policy levers including the European Competitiveness Fund\, EU Inc. and STEP regulation. \n\n\n\nSME Breakfast: The engine of innovation\, the SME breakfast will bring together the entrepreneurs that translate Europe’s research excellence into products\, delivering economic growth and supply chain resilience. The meeting will discuss their challenges and needs\, resulting in the 2026 SME Statement for Industrial Biotechnology\, published following the conference. \n\n\n\n25% discount for EuropaBio’s network: BIEUEB \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/bio-innovations-europe-2026/
CATEGORIES:External,Industrial Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-37.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260611T090000
DTEND;TZID=Europe/Brussels:20260611T133000
DTSTAMP:20260525T184238
CREATED:20260424T102431Z
LAST-MODIFIED:20260424T102433Z
UID:9607-1781168400-1781184600@www.europabio.org
SUMMARY:European Biotech Forum 2026
DESCRIPTION:EuropaBio is a proud sponsor of the European Biotech Forum 2026. \n\n\n\nBiotechnology is becoming a decisive capability for Europe’s competitiveness\, industrial resilience and strategic autonomy. But Europe enters the next institutional cycle with a fragmented policy landscape\, uneven regulatory capacity\, and persistent scale-up barriers. The Commission’s Biotech Communication I and Biotech Communication II set out an initial toolbox\, but fall short of an end-to-end industrial framework comparable to the US. The gap between ambition and execution remains significant. To what extent do these communications address the core challenges of Europe’s biotech sector? Where are the structural gaps that still block growth and industrial deployment? \n\n\n\n\nMore Info & Registration Here
URL:https://www.europabio.org/event/european-biotech-forum-2026/
CATEGORIES:EuropaBio,External,Healthcare Biotech,Industrial Biotech,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/04/Event-Banners-Website-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20260923T080000
DTEND;TZID=Europe/Brussels:20260923T200000
DTSTAMP:20260525T184238
CREATED:20260413T122644Z
LAST-MODIFIED:20260413T122833Z
UID:9571-1790150400-1790193600@www.europabio.org
SUMMARY:Prague.bio Conference 2026
DESCRIPTION:Join our Director General Dr Claire Skentelbery at the 4th edition of Prague.bio Conference! \n\n\n\nIf you want to meet and network with biotech leaders shaping the CEE region\, Prague.bio Conference 2026 is the place to be \n\n\n\nExpect 400+ participants\, partnering via the conference app\, inspiring keynotes\, panel discussions\, hands-on workshops\, and pitch & poster sessions. \n\n\n\n \n\n\n\n\nMore Info Here & Tickets
URL:https://www.europabio.org/event/prague-bio-conference-2026/
CATEGORIES:External,National Associations
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/04/Event-Banners-Website-4.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Brussels:20261026T080000
DTEND;TZID=Europe/Brussels:20261028T200000
DTSTAMP:20260525T184238
CREATED:20260219T132453Z
LAST-MODIFIED:20260219T132456Z
UID:9482-1793001600-1793217600@www.europabio.org
SUMMARY:World Orphan Drug Congress 2026
DESCRIPTION:The World Orphan Drug Congress Europe is the largest and most established event globally for orphan drugs and rare diseases. \n\n\n\nJoin over 1\,800 senior industry leaders\, gain insights from 250+ expert speakers\, and connect with over 100 exhibitors driving progress across the entire orphan drug lifecycle. From regulatory strategy and market access to patient engagement and the latest breakthroughs in gene and cell therapies\, the congress delivers practical insights you can apply immediately. \n\n\n\nNetwork with the most senior individuals across the industry\, including leaders in R&D\, gene therapy\, rare diseases\, precision/personalised medicine\, genetic disorders\, patient advocacy and engagement\, associations in ATMPs\, investors\, regulatory affairs professions\, governmental bodies\, and more… \n\n\n\n\nMore Info Here
URL:https://www.europabio.org/event/world-orphan-drug-congress-2026/
CATEGORIES:External,Healthcare Biotech
ATTACH;FMTTYPE=image/png:https://www.europabio.org/wp-content/uploads/2026/02/Event-Banners-Website-42.png
END:VEVENT
END:VCALENDAR